<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17168">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883387</url>
  </required_header>
  <id_info>
    <org_study_id>15-2448</org_study_id>
    <nct_id>NCT02883387</nct_id>
  </id_info>
  <brief_title>CT-Angiography Prior to DIEP Flap Breast Reconstruction a Randomized Controlled Trial</brief_title>
  <official_title>CT-Angiography Prior to DIEP Flap Breast Reconstruction a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will Investigate whether or not preoperative computed tomography (CT) angiography
      will lower operative times and post operative complications for breast reconstruction
      performed with a deep inferior epigastric artery perforator flap (DIEP).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Operative Time</measure>
    <time_frame>Time of incision to incision closure</time_frame>
    <description>Time required to perform breast reconstruction with DIEP flap</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Preoperative CT Angiography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive preoperative CT angiography to map the blood vessels potentially used for reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Imaging Preoperatively</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No preoperative vessel mapping will be done</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preoperative CT angiography</intervention_name>
    <description>Patients will receive a CT scan to map the blood vessels to be used during surgery for breast reconstruction</description>
    <arm_group_label>Preoperative CT Angiography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Preoperative Imaging</intervention_name>
    <description>No imaging will be done to map blood vessels prior to surgery</description>
    <arm_group_label>No Imaging Preoperatively</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planning breast reconstruction with DIEP flap

          -  Age 18 to 75 years

        Exclusion Criteria:

          -  Mild to moderate loss of kidney function (Estimated Glomerular Filtration Rate (eGFR)
             &lt; 60)

          -  Decisionally challenged

          -  Pregnant

          -  Hepatic failure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David W Mathes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seth Tebockhorst, MD</last_name>
    <phone>3032661801</phone>
    <email>seth.tebockhorst@ucdenver.edu</email>
  </overall_contact>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 25, 2016</lastchanged_date>
  <firstreceived_date>August 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DIEP flap</keyword>
  <keyword>Deep inferior epigastric artery perforator flap</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
